Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis
Purpose Breast cancer (BC) is characterized by concealed onset, delayed diagnosis, and high fatality rates making it particularly dangerous to patients’ health. The purpose of this study was to use comprehensive bioinformatics analysis and experimental verification to find a new biomarker for BC dia...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PeerJ Inc.
2021-09-01
|
| Series: | PeerJ |
| Subjects: | |
| Online Access: | https://peerj.com/articles/12147.pdf |
| _version_ | 1797419718149144576 |
|---|---|
| author | Min Liu Fei Mo Xiaohan Song Yun He Yan Yuan Jiaoyan Yan Ye Yang Jian Huang Shu Zhang |
| author_facet | Min Liu Fei Mo Xiaohan Song Yun He Yan Yuan Jiaoyan Yan Ye Yang Jian Huang Shu Zhang |
| author_sort | Min Liu |
| collection | DOAJ |
| description | Purpose Breast cancer (BC) is characterized by concealed onset, delayed diagnosis, and high fatality rates making it particularly dangerous to patients’ health. The purpose of this study was to use comprehensive bioinformatics analysis and experimental verification to find a new biomarker for BC diagnosis. Methods We comprehensively analyzed microRNA (miRNA) and mRNA expression profiles from the Gene Expression Omnibus (GEO) and screened out differentially-expressed (DE) miRNAs and mRNAs. We used the miRNet website to predict potential DE-miRNA target genes. Using the Database for Annotation, Visualization and Integrated Discovery (DAVID), we performed Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses on overlapping potential target genes and DE-mRNAs. The protein-protein interaction (PPI) network was then established. The miRNA-mRNA regulatory network was constructed using Cytoscape and the analysis results were visualized. We verified the expression of the most up-regulated DE-miRNA using reverse transcription and a quantitative polymerase chain reaction in BC tissue. The diagnostic value of the most up-regulated DE-miRNA was further explored across three levels: plasma-derived exosomes, cells, and cell exosomes. Results Our comprehensive bioinformatics analysis and experimental results showed that hsa-miR-21-5p was significantly up-regulated in BC tissue, cells, and exosomes. Our results also revealed that tumor-derived hsa-miR-21-5p could be packaged in exosomes and released into peripheral blood. Additionally, when evaluating the diagnostic value of plasma exosomal hsa-miR-21-5p, we found that it was significantly up-regulated in BC patients. Receiver operating characteristic (ROC) analysis also confirmed that hsa-miR-21-5p could effectively distinguish healthy people from BC patients. The sensitivity and specificity were 86.7% and 93.3%, respectively. Conclusion This study’s results showed that plasma exosomal hsa-miR-21-5p could be used as a biomarker for BC diagnosis. |
| first_indexed | 2024-03-09T06:52:22Z |
| format | Article |
| id | doaj.art-a435755c42f9481083d4862c07a2b250 |
| institution | Directory Open Access Journal |
| issn | 2167-8359 |
| language | English |
| last_indexed | 2024-03-09T06:52:22Z |
| publishDate | 2021-09-01 |
| publisher | PeerJ Inc. |
| record_format | Article |
| series | PeerJ |
| spelling | doaj.art-a435755c42f9481083d4862c07a2b2502023-12-03T10:24:35ZengPeerJ Inc.PeerJ2167-83592021-09-019e1214710.7717/peerj.12147Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosisMin Liu0Fei Mo1Xiaohan Song2Yun He3Yan Yuan4Jiaoyan Yan5Ye Yang6Jian Huang7Shu Zhang8Department of Laboratory Medicine, Sichuan Maternal and Child Health Hospital, Chengdu, Sichuan Province, ChinaDepartment of Clinical Laboratory, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, ChinaDepartment of Basic Clinical Laboratory Medicine, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou Province, ChinaDepartment of Clinical Laboratory, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, ChinaDepartment of Basic Clinical Laboratory Medicine, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou Province, ChinaDepartment of Basic Clinical Laboratory Medicine, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou Province, ChinaDepartment of Basic Clinical Laboratory Medicine, School of Clinical Laboratory Science, Guizhou Medical University, Guiyang, Guizhou Province, ChinaDepartment of Clinical Laboratory, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, ChinaDepartment of Clinical Laboratory, Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou Province, ChinaPurpose Breast cancer (BC) is characterized by concealed onset, delayed diagnosis, and high fatality rates making it particularly dangerous to patients’ health. The purpose of this study was to use comprehensive bioinformatics analysis and experimental verification to find a new biomarker for BC diagnosis. Methods We comprehensively analyzed microRNA (miRNA) and mRNA expression profiles from the Gene Expression Omnibus (GEO) and screened out differentially-expressed (DE) miRNAs and mRNAs. We used the miRNet website to predict potential DE-miRNA target genes. Using the Database for Annotation, Visualization and Integrated Discovery (DAVID), we performed Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses on overlapping potential target genes and DE-mRNAs. The protein-protein interaction (PPI) network was then established. The miRNA-mRNA regulatory network was constructed using Cytoscape and the analysis results were visualized. We verified the expression of the most up-regulated DE-miRNA using reverse transcription and a quantitative polymerase chain reaction in BC tissue. The diagnostic value of the most up-regulated DE-miRNA was further explored across three levels: plasma-derived exosomes, cells, and cell exosomes. Results Our comprehensive bioinformatics analysis and experimental results showed that hsa-miR-21-5p was significantly up-regulated in BC tissue, cells, and exosomes. Our results also revealed that tumor-derived hsa-miR-21-5p could be packaged in exosomes and released into peripheral blood. Additionally, when evaluating the diagnostic value of plasma exosomal hsa-miR-21-5p, we found that it was significantly up-regulated in BC patients. Receiver operating characteristic (ROC) analysis also confirmed that hsa-miR-21-5p could effectively distinguish healthy people from BC patients. The sensitivity and specificity were 86.7% and 93.3%, respectively. Conclusion This study’s results showed that plasma exosomal hsa-miR-21-5p could be used as a biomarker for BC diagnosis.https://peerj.com/articles/12147.pdfBreast cancerDiagnosisBioinformaticsBiomarkermicroRNAExosome |
| spellingShingle | Min Liu Fei Mo Xiaohan Song Yun He Yan Yuan Jiaoyan Yan Ye Yang Jian Huang Shu Zhang Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis PeerJ Breast cancer Diagnosis Bioinformatics Biomarker microRNA Exosome |
| title | Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis |
| title_full | Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis |
| title_fullStr | Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis |
| title_full_unstemmed | Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis |
| title_short | Exosomal hsa-miR-21-5p is a biomarker for breast cancer diagnosis |
| title_sort | exosomal hsa mir 21 5p is a biomarker for breast cancer diagnosis |
| topic | Breast cancer Diagnosis Bioinformatics Biomarker microRNA Exosome |
| url | https://peerj.com/articles/12147.pdf |
| work_keys_str_mv | AT minliu exosomalhsamir215pisabiomarkerforbreastcancerdiagnosis AT feimo exosomalhsamir215pisabiomarkerforbreastcancerdiagnosis AT xiaohansong exosomalhsamir215pisabiomarkerforbreastcancerdiagnosis AT yunhe exosomalhsamir215pisabiomarkerforbreastcancerdiagnosis AT yanyuan exosomalhsamir215pisabiomarkerforbreastcancerdiagnosis AT jiaoyanyan exosomalhsamir215pisabiomarkerforbreastcancerdiagnosis AT yeyang exosomalhsamir215pisabiomarkerforbreastcancerdiagnosis AT jianhuang exosomalhsamir215pisabiomarkerforbreastcancerdiagnosis AT shuzhang exosomalhsamir215pisabiomarkerforbreastcancerdiagnosis |